Cancer Registry for Familial and Sporadic Tumors (CuRe-FAST) - Registro dei tumori familiari e sporadici: Il fibrosarcoma epitelioide sclerosante

Title

Code

SEF

Type

Sperimentale

Start Year

2022

Status

Terminato

Principal Investigator

051-6366665

alberto.righi@ior.it

Righi Alberto, MD

Anatomy and Pathological Histology

Operational unit that carry out the study

departmental simple unit

Anatomia e istologia patologica

Head

Gambarotti Marco, MD

Go to the details >>

Description

Studio promosso da Children’s Cancer Therapy Development Institute USA

Documents and Videos attachament

Attachment

Nulla osta alla conduzione dello studio prot. SEF

Wednesday 14 December 2022, 15:29

PG0018295_2022_Stampa_unica.pdf

You might also be interested in

Clinical Trial

A Phase 2/3, Randomized, Multicenter Study to Evaluate AL102 in Patients with Progressing Desmoid Tumors

Clinical Trial

Phase study 1/2 to evaluate palbociclib (IBRANCE®) in combination with irinotecan and temozolomide or in combination with topotecan and cyclophosphamide in pediatric patients with recurrent orrefractory solid tumors

IRCCS

ISTITUTO ORTOPEDICO RIZZOLI

Cancer Registry for Familial and Sporadic Tumors (CuRe-FAST) - Registro dei tumori familiari e sporadici: Il fibrosarcoma epitelioide sclerosante

Principal Investigator

Operational unit that carry out the study

Description

Documents and Videos attachament

You might also be interested in

Sito Web Istituto Ortopedico Rizzoli

Cancer Registry for Familial and Sporadic Tumors (CuRe-FAST) - Registro dei tumori familiari e sporadici: Il fibrosarcoma epitelioide sclerosante

Principal Investigator

Operational unit that carry out the study

Description

Documents and Videos attachament

You might also be interested in